GTJClass II
Antisera, All Groups, N. Meningitidis
21 CFR 866.3390 / Microbiology
GTJ is the FDA product code for Antisera, All Groups, N. Meningitidis, a class II device type, regulated under 21 CFR 866.3390. As of , FDA records hold 16 510(k) clearances under this code, the most recent dated , and 5 recalls.
Classification record
- Product code
- GTJ
- Device name
- Antisera, All Groups, N. Meningitidis
- Regulation
- 21 CFR 866.3390
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 16
- Ingested recalls
- 5
Clearances, product code GTJ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1977 | 1 |
| 1982 | 1 |
| 1983 | 1 |
| 1984 | 2 |
| 1985 | 4 |
| 1986 | 2 |
| 1987 | 1 |
| 1989 | 1 |
| 1991 | 1 |
| 1992 | 1 |
| 1996 | 1 |
Applicants with the most clearances
Product code GTJ| Applicant | Clearances |
|---|---|
| Wellcome Diagnostics | 5 |
| Armkel, LLC | 3 |
| BD Becton Dickinson Vacutainer Systems Preanalytic | 3 |
| Pharmacia, Inc. | 2 |
| Burroughs Wellcome Co. | 1 |
| Microscan Div. Baxter Healthcare Corp. | 1 |
| Vitek Systems, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
